Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| classical monocyte | 13 studies | 26% ± 10% | |
| platelet | 11 studies | 77% ± 21% | |
| smooth muscle cell | 9 studies | 26% ± 14% | |
| glutamatergic neuron | 9 studies | 69% ± 20% | |
| type II pneumocyte | 8 studies | 32% ± 12% | |
| pericyte | 8 studies | 24% ± 6% | |
| megakaryocyte | 6 studies | 79% ± 16% | |
| oligodendrocyte | 5 studies | 21% ± 5% | |
| endothelial cell | 4 studies | 38% ± 22% | |
| GABAergic neuron | 4 studies | 19% ± 3% | |
| non-classical monocyte | 3 studies | 30% ± 5% | |
| astrocyte | 3 studies | 20% ± 5% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 8 studies | 42% ± 20% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 74% | 43132.63 | 1950 / 2642 | 96% | 373.27 | 678 / 705 |
| lung | 77% | 2842.73 | 443 / 578 | 82% | 45.66 | 945 / 1155 |
| kidney | 34% | 813.43 | 30 / 89 | 68% | 18.15 | 615 / 901 |
| ureter | 0% | 0 | 0 / 0 | 100% | 33.35 | 1 / 1 |
| thymus | 3% | 54.44 | 21 / 653 | 93% | 34.26 | 560 / 605 |
| ovary | 8% | 136.27 | 15 / 180 | 85% | 39.85 | 365 / 430 |
| uterus | 9% | 148.35 | 15 / 170 | 79% | 21.46 | 361 / 459 |
| pancreas | 0% | 0 | 0 / 328 | 83% | 14.59 | 148 / 178 |
| lymph node | 0% | 0 | 0 / 0 | 83% | 22.81 | 24 / 29 |
| bladder | 5% | 75.90 | 1 / 21 | 76% | 18.92 | 384 / 504 |
| peripheral blood | 80% | 9475.54 | 747 / 929 | 0% | 0 | 0 / 0 |
| spleen | 78% | 2552.54 | 187 / 241 | 0% | 0 | 0 / 0 |
| skin | 4% | 74.97 | 77 / 1809 | 71% | 16.33 | 334 / 472 |
| intestine | 1% | 8.85 | 5 / 966 | 74% | 11.22 | 388 / 527 |
| stomach | 0% | 5.30 | 1 / 359 | 72% | 11.28 | 207 / 286 |
| adrenal gland | 0% | 0 | 0 / 258 | 71% | 133.30 | 163 / 230 |
| blood vessel | 68% | 2367.70 | 910 / 1335 | 0% | 0 | 0 / 0 |
| esophagus | 0% | 6.57 | 6 / 1445 | 58% | 8.37 | 106 / 183 |
| breast | 3% | 52.78 | 12 / 459 | 54% | 7.42 | 609 / 1118 |
| tonsil | 0% | 0 | 0 / 0 | 40% | 6.63 | 18 / 45 |
| liver | 0% | 0 | 0 / 226 | 38% | 5.54 | 153 / 406 |
| prostate | 0% | 0 | 0 / 245 | 36% | 4.16 | 180 / 502 |
| eye | 0% | 0 | 0 / 0 | 13% | 1.75 | 10 / 80 |
| adipose | 7% | 127.64 | 85 / 1204 | 0% | 0 | 0 / 0 |
| heart | 4% | 71.98 | 35 / 861 | 0% | 0 | 0 / 0 |
| muscle | 0% | 2.43 | 1 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0007165 | Biological process | signal transduction |
| GO_0007399 | Biological process | nervous system development |
| GO_0005829 | Cellular component | cytosol |
| GO_0005516 | Molecular function | calmodulin binding |
| Gene name | NRGN |
| Protein name | Neurogranin (Ng) (RC3) [Cleaved into: NEUG(55-78)] |
| Synonyms | |
| Description | FUNCTION: Acts as a 'third messenger' substrate of protein kinase C-mediated molecular cascades during synaptic development and remodeling. Binds to calmodulin in the absence of calcium (By similarity). . |
| Accessions | ENST00000412681.2 ENST00000284292.11 Q92686 |